Skip to main content

Table 7 Major bleeding Analysis with Bootstrapped DerSimonian-Laird random-effects model calculated by STATA

From: Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis

STUDY

Overall

Subgroup: VHD

Subgroup: TAVI

Sensitivity Test

Harbord’s modified test

RR

95%CI

Weight(%)

RR

95%CI

Weight(%)

RR

95%CI

Weight(%)

RR

95%CI

p-Value

ARISTOTLE, 2015

0.809

0.623, 1.049

19.42

0.809

0.623, 1.049

24.61

 

0.698

0.395, 1.234

0.585

ENGAGE AF-TIMI 48, 2017

0.568

0.432, 0.749

19.27

0.568

0.432, 0.749

24.43

0.756

0.437, 1.31

RE-LY, 2016

0.39

0.319, 0.477

19.99

0.39

0.319, 0.477

25.27

0.831

0.592, 1.169

ROCKET AF, 2014

1.124

0.965, 1.309

20.35

1.124

0.965, 1.309

25.69

0.621

0.422, 0.915

Seeger, 2017

0.664

0.216, 2.039

8.78

 

0.664

0.216, 2.039

34.06

0.72

0.446, 1.164

Geis, 2018

1.117

0.498, 2.503

12.19

1.117

0.498, 2.503

65.94

0.671

0.411, 1.093

Overall

0.714

0.461, 1.105

100

0.672

0.402, 1.122

100

0.935

0.486, 1.801

100

0.715

0.455, 1.122

Heterogeneity Measures

Value

df

p-value

Value

df

p-value

Value

df

p-value

  

Cochran’s Q

71.36

5

0

74.19

3

0

0.055

1

0.459

Heterogeneity Measures

Value (95%CI)

Value (95%CI)

Value (95%CI)

I2 (%)

91.12

83.43, 95.24

95.58

91.54, 97.69

0

0.00, 100.00

H2

11.26

6.03, 21.00

22.62

11.82, 43.30

1

/

tau2 (BDL)

0.238

0.261

0